Therapeutic Effectiveness of Interferon-α2b against COVID-19 with Community-Acquired Pneumonia: The Ukrainian Experience
Oleksandr Kamyshnyi(I.Horbachevsky Ternopil National Medical University), Olena Moshynets(National Academy of Sciences of Ukraine), Valentyn Oksenych(University of Bergen), Mykhailo Buchynskyi(I.Horbachevsky Ternopil National Medical University), Iryna Kamyshna(I.Horbachevsky Ternopil National Medical University), Geert Potters(University of Antwerp), G. D. Koval(Yuriy Fedkovych Chernivtsi National University), Katerina Lyubomirskaya(Zaporizhzhia State Medical and Pharmaceutical University), Denis E. Kainov(Norwegian University of Science and Technology), Olha Kobevko(Yuriy Fedkovych Chernivtsi National University)
Cited by 25
Related Papers
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses
|Cell Reports Medicine|2021|219
Effects of metformin on the gut microbiota: A systematic review
|Molecular Metabolism|2023|91
The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin
|Biomedicine & Pharmacotherapy|2023|70
Modulating Nitric Oxide: Implications for Cytotoxicity and Cytoprotection
|Antioxidants|2024|64